For cows on d 137 (n = 6), 180 (n = 8). 226 (n = 9) and 250 (n = 5) of gestation (Exp. 1). concentrations of insulin and glucose were two-to three-fold less (P < concentrations of insulin and glucose in maternal and fetal plasmas and of growth hormone in maternal plasma remained relatively constant in samples collected every 30 min for 3 h. In contrasf growth hormone concentrations in fetal venous plasma were highly variable and appeared to be episodic, with pulses of 10 to 60 ngtml in amplitude. No significant correlations were found among concentrations of insulin, glucose and growth hormone in fetal venous plasma. When samples were collected every 15 min for 4 h from cows (n = 5) on d 198 of gestation (Exp. 31, episodes of growth hormone in fetal venous plasma were irregular in amplitude and frequency. Thus, as observed in other mammalian species, bovine fetuses were hypoglycemic even though concentrations of growth hormone were 10-to 20-fold greater and concentrations of insulin were two-to three-fold less than in maternal plasma. In addition, the irregular pattern of growth hormone concentrations indicates that mechanisms for control of growth hormone secretion are poorly developed in the bovine fetus. ( 
Introduction
Glucose is a major substrate of oxidative metabolism in mammalian fetuses, including 'those of cows and sheep (Battaglia and Meschia, 1978; Reynolds et al., 1986) . In fetal lambs, destruction of the pituitary gland decreases plasma concentrations of growth hormone and glucose and also reduces liver glycogen content (Liggins and Kennedy, 1968; Bassett and Gluckman, 1986) . Infusion of growth hormone into hypophysectomized fetal lambs increases plasma concentrations of glu-725 cose and insulin (Parkes and Bassett, 1985) .
Infusion of insulin into the circulation of the ovine fetus produces fetal hypoglycemia while increasing fetal glucose uptake (Colwill et al., 1970; Hay et al., 1985) . Infusion of glucose into the sheep fetus decreases growth hormone and increases insulin concentrations in plasma (Bassett et al., 1970; Philipps et al., 1978) . Thus, growth hormone appears to have hyperglycemic effects, whereas insdin has hypoglycemic effects, in the sheep fetus.
Although plasma concentrations of growth hormone, insulin and glucose have been reported for fetal calves throughout gestation (Oxender et al., 1972; Grigsby et al., 1974; D'Agostino et al., 1985; Reynolds et al., 1986) , these compounds were measured either in separate studies or in samples obtained at surgery. The purposes of our studies were to determine, in unanesthetized animals, the concentrations of and relationships among growth hormone, insulin and glucose in bovine maternal and fetal plasmas at several stages of gestation.
Meterials and Methods
For Exp. 1, 28 Hereford cows were used. Cows were fed a corn silage diet at a level calculated to maintain BW as described previously (Ferrell et al., 1983; Reynolds et al., 1985) and were fed twice daily (0800 and 1600). Cows were assigned randomly to surgery on d 132 f l (mean f SE, n = 6), 176 f 1 (n = 8). 220 * 1 (n = 9) or 245 f 2 (n = 5 ) of gestation (d 0 = day of breeding). Beginning at least 30 d before surgery, each cow was confined to an individual stall for several hours daily to become acclimated to the personnel and facilities. Feed was withheld from each cow for 48 h and water for 12 h before surgery. Procedures for induction and maintenance of general anesthesia and implantation of maternal and fetal indwelling catheters have been described previously (Reynolds et al., 1986; Reynolds and Ferrell, 1987) . A catheter was implanted into the artery of the gravid uterine horn. For fetuses on d 176 and 220 of gestation a catheter also was implanted into an umbilical vein. For fetuses on d 132 and 245 of gestation, a catheter was implanted into a placental vein and advanced until its tip was within the lumen of, or in close proximity to, the umbilical vein.
Four to six days after surgery, uterine arterial (10 ml) and umbilical or placental venous (5 ml) blood samples were collected for 3 h at 30-min intervals into tubes containing EDTA (1.5 mglml). For all cows, the collection period began between 0800 and 1300, and cows were not fed during the collection period. During the collection period, maternal and fetal heart rates were determined hourly by observation of the meniscus in uterine arterial and fetal venous catheters as described by Reynolds et al. (1985) . To monitor fetal health, samples also were collected from fetal veins at t = 0, 60, 120 and 180 min and from uterine arteries at t = 30, 90 and 150 min into heparinized capillary tubes (250-pl Natelson tubes)5 for determination of oxygen content. All samples were uansported, on ice, to the laboratory within 15 rnin of collection. Oxygen content of each sample was determined using a blood 0, content analyzer6 as described previously (Ferrell et al., 1983; Reynolds et al., 1985) . In addition, hematocrits were determined. For each cow, plasma samples were pooled from a given vessel and stored at -20°C until assayed for growth hormone, insulin and glucose concentrations.
In Exp. 2, uterine arterial and umbilical venous catheters were implanted into Hereford cows (n = 6) on d 191 f 1 of gestation. Four to nine days after surgery, blood samples were collected as described above, and heart rates, @ contents and hematocrits were determined. For this study, plasma samples were not pooled but were stored individually at -20°C until they were assayed for growth hormone, insulin and glucose. Oxygen content of each sample was determined as in Exp. 1. For two of the cows, blood sampling was repeated 4 to 7 d after initial sampling.
Exp. 3 was designed to define the pattern of growth hormone concentrations in the fetus because episodic patterns were observed in Exp. 2. Umbilical venous catheters were implanted into five Hereford cows on d 177 f 1 of gestation. At 8 to 18 d after surgery, umbilical venous blood samples (2 ml) were collected every 15 min for 4 h. Fetal heart rates and umbilical venous 02 contents were determined at hourly intervals. Plasma was collected and frozen as described for Exp until it was assayed for growth hormone.
Plasma samples were assayed for glucose concentrations as described by Reynolds et al. (1986) . Concentrations of growth hormone in maternal and fetal plasmas were determined by RIA as reported previously (Klindt and Maurer, 1986) . The assay utilized NIH-oGH-I-3 (biopotency = 1.7 IU/mg) as the radioiodination preparation, USDA-bGH-B-1 (biopotency = 1.4 IU/mg) as the mfemce standard and NIAMDD-anti-oGH-2 as the primary antiserum. Sensitivity of the assay, defined as the concentration of reference standard that displaced 5% of the radioligand, was 54.8 pg/ tube. All samples were run in a single assay, and intra-assay variation was determined by assaying replicates (n = 10) of a pool of fetal plasma in the same assay. The resulting concentration of growth hormone in the fetal plasma pool was 68.1 f 4.0 ng/ml (CV = Maternal and fetal plasmas and fetal pituitary extract assayed in different volumes all yielded inhibition curves that were parallel to that of the bovine growth hormone reference standard (Figure 1 ). Concentrations of insulin in maternal and fetal plasmas were assayed using a commercial RIA'. The assay utilized porcine insulin as the radioiodination preparation, bovine zinc insulin (26.6 IU/mg)* as the reference standard and guinea pig antiporcine insulin as the antiserum. Sensitivity of the assay was .4U pU/tube. All samples were run in a single assay, and intra-assay variability was determined by assaying replicates (n = 6) of a pool of maternal plasma in the same assay. The resulting concentration of insulin in the maternal plasma pool was 16.9 f .2 pU/ml (CV = 3.1%). To further validate the insulin assay, a fetal and a maternal bovine pancreas were homogenized in five volumes of .15 M NaCl, incubated at 4'C for 1 h and centrifuged at 700 x g for 30 min. The resulting supernatant fluids were diluted further with assay buffer to yield bovine fetal and maternal pancreatic extracts with final dilutions of 1: 35,000 and 1:250, respectively. These pancreatic extracts, a sample of fetal plasma and a sample of maternal plasma were assayed at volumes of 25, 50, 100 and 200 pl. The fetal plasma sample was assayed at an additional volume of 400 pl. Maternal and fetal plasmas and pancreatic extracts assayed in different volumes all yielded inhibition curves that were parallel to that of the bovine insulin reference standard (Figure 2) . Data for Exp. 1 and 2 were analyzed statistically using least squares analysis of variance procedures for factorial and repeated measures designs (Wilkinson, 1986) . Differences between specific means were evaluated using Bonferroni's test (Kirk, 1982) , when the F test was significant ( P < .05). In addition, linear correlation procedures were used to evaluate relationships among fetal plasma concentrations of growth hormone, insulin and glucose in Exp. 2 (Steel and Tome, 1980) . Data are reported as means f SE.
5.8%

Resu Its
In Exp. 1, maternal and fetal heart rates were 67 f 1 and 143 f 2 beats/min, and maternal and fetal hematocrits were 30 f .4 and 30 * .5%, respectively, which are within normal ranges reported previously (Earl et al., 1980; Reynolds et al., 1985 Reynolds et al., . 1986 ). Concentrations of 0 2 in maternal and fetal blood remained constant across day of gestation and were 6.4 f .1 and 4.2 f .1 mM which are similar to values reported previously (Comline and Silver, 1976; Ferrell et al., 1983; Reynolds et al., 1985) . Concentrations of insulin and glucose in uterine arterial and fetal venous plasmas did not vary with day of gestation and no day of gestation x site of sampling interaction was found ( about threefold greater (P e .01) and those of glucose were about twofold greater (P < .Ol)
than corresponding values in fetal venous plasma (Table 1) . Concentrations of growth hormone in uterine arterial plasma, however,
were 10-to 20-fold less (P < .01) than concentrations in fetal venous plasma ( Table  1) . In uterine arterial plasma, concentrations of growth hormone did not change with stage of gestation. In fetal venous plasma, however, concentrations of growth hormone on d 137
and 180 were less (P < .01) than on d 226 and 250 ( Table 1) . In Exp. 2, maternal and fetal heart rates were 67 f 3 and 153 f 5 beats/min and hematocrits were 28 f .7 and 31 f .8%, respectively. Concentrations of 0 2 in maternal and fetal blood averaged 5.7 f .2 and 4.1 f .8 mM. No significant correlations were found among fetal plasma concentrations of growth hormone, insulin or glucose when either individual values or means were used. As observed in Exp. 1, concentrations of insulin and glucose were greater (P c .Ol) in uterine arterial than in fetal venous plasma, whereas concentrations of growth hormone were less (P e .01) in uterine arterial than in fetal venous plasma ( Table 2) . Concentrations of insulin and glucose in uterine arterial and fetal venous plasmas remained constant during the 3-h sampling period ( Table 2) . Concentrations of growth hormone in uterine arterial plasma also remained relatively constant (Figure 3) . Concentrations of growth hormone in fetal venous plasma, however, were highly variable (Table 2 ) and appeared to be episodic in seven of eight fetuses (Figure 3) . Pulses of growth hormone in fetal venous plasma as great as 60 ng/ml in amplitude were observed. Uterine artery 3.3 f .8 4.1 f 1.7 2.5 f .4 3.7 f 1.4 2.4 f .3 3.3 k .8 2.9 f .5 tal veinb 74.5 f 6.7 54.2 f 7.6 70.4 f 6.3 70.8 f 5.5 60.7 f 7.9 71.4 f 6.8 60.8 f 7.9
Uterine. artery 14.0 f 1.1 12.6 f .6 12.6 f .9 10.8 f .3 10.8 f .4 9.4 f .4 10.1 * .5
Fetal vein 5.8 f .5 5.9 f .4 5.9 f .5 5.9 k .4 6.0 f .5 5.8 f .5 6.0 f .4
Uterine artery 3.9 f .14 4.1 f 20 3.9 f .18 3.8 f .16 3.8 f .17 3.8 f .I2 3.8 f .I5
Fetal vein 2.0 f .09 2.0 f .12 2.0 f .12 1.9 f .12 1.9 f .09 1.9 f .09 1.9 f .07 For fetuses in Exp. 3, heart rate was 142 f 1 beats/min, and umbilical venous 0 2 was 4.3 +_ .3 mM. When umbilical venous samples were collected every 15 min for 4 h, growth hormone concentrations again were episodic. However, episodes of fetal growth hormone were irregular both in frequency and in amplitude (Figure 4) .
Discussion
Even though insulin concentrations are less and growth hormone concentrations are greater in fetal plasma than in maternal plasma, bovine fetuses were hypoglycemic compared with the maternal system. Similar observations have been made for other mammalian fetuses (Girard et al., 1979; Gluckman et al., 1981) .
Because ovine plasma glucose concentrations are increased by growth hormone and decreased by insulin (Colwill et al., 1970; Parkes and Bassett, 1985) . one would expect the fetus to be hyperglycemic in relation to the maternal system because of the high fetal growth hormone to insulin ratio. However, large changes in plasma growth hormone caused relatively minor changes in plasma glucose concentrations in fetal sheep (Parkes and Bassea, 1985) . Conversely, ovine fetal glucose concentrations and utilization seem to be highly responsive to insulin (Colwill et al., 1970 Hay et al., 1985 . Thus, fetal tissues may be relatively more responsive to insulin than to growth hormone. Perhaps growth hormone has a role in regulation of fetal metabolism because hypophysectomized fetuses exhibit reduced concentrations of plasma glucose and liver glycogen as well as altered development of adipose and muscle tissues (Barnes et al., 1977; Hausman et al., 1981 Hausman et al., , 1982 Bassett and Gluckman, 1986) . In addition, growth hormone may antagonize the metabolic effects of insulin in hypophysectomized fetuses (Parkes and Basset& 1985) .
Fetal plasma growth hormone in the present study increased from mid to late gestation. A similar pattern of increasing plasma growth hormone has been observed for sheep and pig fetuses during late gestation (Klindt and Stone, 1984; Bassett and Gluckman, 1986) . In monkey and human fetuses, concentrations of plasma growth hormone appear to decrease during late gestation (Gluckman et al., 1981) . No correlation was found among plasma concentrations of growth hormone, insulin and glucose in bovine fetuses in the present study. In ovine fetuses, a highly significant correlation between plasma insulin and glucose has been reported ( Bassett and Madill, 1974b) . However, Bassett and Madill (1974b) utilized maternal fasting to widen the variation in maternal and fetal plasma glucose concentrations. In the present study, little variation was observed for maternal or fetal glucose, which may have accounted for the lack of correlation between these characteristics.
The patterns observed in Exp. 2 indicated that fetal growth hormone varied in a pulsatile manner. When more frequent samples were taken in Exp. 3, however, patterns of growth hormone appeared to be episodic but irregular both in amplitude and in frequency. A similar irregular pattern of growth hormone concentrations was observed in fetal lambs (Bassett and Madill, 1974a) . In addition, the pituitary gland of fetal lambs appears relatively resistant to suppression of growth hormone concentrations by somatostatin (Gluckman et al., 1979; McMilian et al., 1979) . Gluckman et al. (1981) suggested that high growth hormone concentrations in fetuses are due to an "immaturity in central nervous system control of pituitary function." Our observations support this hypothesis because growth hormone in the bovine fetus not only exhibits high plasma concentrations but also appears to vary randomly.
Implications
Concentrations of insulin and glucose were 2-to 3-fold less and those of growth hormone were 10-to 20-fold greater in bovine fetal blood than in maternal blood. No significant correlations were found among concentrations of insulin, glucose and growth hormone in fetal blood. Although growth hormone appeared to be secreted episodically in fetuses, episodes were irregular in amplitude and frequency. Thus, mechanisms for control of growth hormone secretion in fetuses of cows may not be fully developed, as has been proposed for fetuses of other species.
